Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT05780034 |
| Title | A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Accutar Biotechnology Inc |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Colorado Blood Cancer Institute | RECRUITING | Denver | Colorado | 80218 | United States | Details |
| Florida Cancer Specialists | RECRUITING | Sarasota | Florida | 34232 | United States | Details |
| The Ohio State University - The James Cancer Hospital and Solove Research Institute | RECRUITING | Columbus | Ohio | 43210 | United States | Details |
| Oregon Health & Science University | RECRUITING | Portland | Oregon | 97239 | United States | Details |
| Tennessee Oncology | WITHDRAWN | Nashville | Tennessee | 37302 | United States | Details |
| University of Texas Southwestern Medical Center | RECRUITING | Dallas | Texas | 75390 | United States | Details |
| Swedish Cancer Institute | RECRUITING | Seattle | Washington | 98104 | United States | Details |